Rentería M E, Schmaal L, Hibar D P, Couvy-Duchesne B, Strike L T, Mills N T, de Zubicaray G I, McMahon K L, Medland S E, Gillespie N A, Hatton S N, Lagopoulos J, Veltman D J, van der Wee N, van Erp T G M, Wittfeld K, Grabe H J, Block A, Hegenscheid K, Völzke H, Veer I M, Walter H, Schnell K, Schramm E, Normann C, Schoepf D, Konrad C, Zurowski B, Godlewska B R, Cowen P J, Penninx B W J H, Jahanshad N, Thompson P M, Wright M J, Martin N G, Christensen H, Hickie I B
Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.
Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Transl Psychiatry. 2017 May 2;7(5):e1116. doi: 10.1038/tp.2017.84.
The aetiology of suicidal behaviour is complex, and knowledge about its neurobiological mechanisms is limited. Neuroimaging methods provide a noninvasive approach to explore the neural correlates of suicide vulnerability in vivo. The ENIGMA-MDD Working Group is an international collaboration evaluating neuroimaging and clinical data from thousands of individuals collected by research groups from around the world. Here we present analyses in a subset sample (n=3097) for whom suicidality data were available. Prevalence of suicidal symptoms among major depressive disorder (MDD) cases ranged between 29 and 69% across cohorts. We compared mean subcortical grey matter volumes, lateral ventricle volumes and total intracranial volume (ICV) in MDD patients with suicidal symptoms (N=451) vs healthy controls (N=1996) or MDD patients with no suicidal symptoms (N=650). MDD patients reporting suicidal plans or attempts showed a smaller ICV (P=4.12 × 10) or a 2.87% smaller volume compared with controls (Cohen's d=-0.284). In addition, we observed a nonsignificant trend in which MDD cases with suicidal symptoms had smaller subcortical volumes and larger ventricular volumes compared with controls. Finally, no significant differences (P=0.28-0.97) were found between MDD patients with and those without suicidal symptoms for any of the brain volume measures. This is by far the largest neuroimaging meta-analysis of suicidal behaviour in MDD to date. Our results did not replicate previous reports of association between subcortical brain structure and suicidality and highlight the need for collecting better-powered imaging samples and using improved suicidality assessment instruments.
自杀行为的病因复杂,对其神经生物学机制的了解有限。神经成像方法提供了一种非侵入性途径,可在体内探索自杀易感性的神经关联。ENIGMA-MDD工作组是一项国际合作项目,评估来自世界各地研究小组收集的数千人的神经成像和临床数据。在此,我们展示了对一个亚组样本(n = 3097)的分析,该样本可获取自杀相关数据。各队列中,重度抑郁症(MDD)患者的自杀症状患病率在29%至69%之间。我们比较了有自杀症状的MDD患者(N = 451)与健康对照者(N = 1996)或无自杀症状的MDD患者(N = 650)的平均皮质下灰质体积、侧脑室体积和总颅内体积(ICV)。报告有自杀计划或自杀未遂的MDD患者与对照组相比,ICV较小(P = 4.12 × 10),体积小2.87%(Cohen's d = -0.284)。此外,我们观察到一个无显著意义的趋势,即有自杀症状的MDD患者与对照组相比,皮质下体积较小,脑室体积较大。最后,在任何脑容量测量指标上,有自杀症状和无自杀症状的MDD患者之间均未发现显著差异(P = 0.28 - 0.97)。这是迄今为止关于MDD患者自杀行为的最大规模神经成像荟萃分析。我们的结果未能重复先前关于皮质下脑结构与自杀性之间关联的报告,并强调了收集更具统计学效力成像样本和使用改进的自杀性评估工具的必要性。